NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/20/2025
Back to search
Official data from USPTO
ONE DOSE PHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
10/22/2025
Trademark type
Combined
Nice classes
5
Filing date
09/24/2014
Registration date
09/08/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/20/2025
Last transaction
10/22/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/11/2015
First use in commerce
04/11/2015
Drawing code
3
Owner type
03
Owner location
DORAL, FL
Examiner
RINGLE,JAMES W
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized lettering of the words "ONE DOSE PHARM" appearing inside of a design of a pill. The word "ONE" appears above the word "DOSE" and the word "PHARM" appears to the right of the words "ONE DOSE".
Holders and representatives
Holders
IMPEX DISTRIBUTION CORP.
Ramos, Nelson F.
Representatives
Meredith Frank Mendez, Esq. MALLOY & MALLOY, P.L.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Nutritional supplements
Publications
History of USPTO decisions and trademark events.
32 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/20/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/20/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/20/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
07/01/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/08/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/19/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/19/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/18/2021
E815
TEAS SECTION 8 & 15 RECEIVED
07/09/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/24/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/24/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/03/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
09/08/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
08/04/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/03/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/31/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/28/2015
IUAF
USE AMENDMENT FILED
06/30/2015
EISU
TEAS STATEMENT OF USE RECEIVED
06/30/2015
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
05/12/2015
PUBO
PUBLISHED FOR OPPOSITION
03/17/2015
NPUB
NOTICE OF PUBLICATION
02/25/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/10/2015
ALIE
ASSIGNED TO LIE
02/10/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/23/2015
CNEA
EXAMINER'S AMENDMENT MAILED
01/23/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
01/22/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/22/2015
DOCK
ASSIGNED TO EXAMINER
01/13/2015
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
10/03/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/02/2014
Continuous trademark protection
Get notified about every new filing that threatens ONE DOSE PHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.